Kevin Atchison
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)AVEO Oncology (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Cholinesterase and Neurodegenerative Diseases, Computational Drug Discovery Methods, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography
Most-Cited Works
- → Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease(2020)434 cited
- → Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor(2012)420 cited
- → Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels(2008)344 cited
- → Acute γ-Secretase Inhibition Improves Contextual Fear Conditioning in the Tg2576 Mouse Model of Alzheimer's Disease(2005)212 cited
- → 3D Timelapse Analysis of Muscle Satellite Cell Motility(2009)177 cited
- → Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein γ-Secretase for the Treatment of Alzheimer’s Disease(2009)157 cited